IDXX Annual FCF
$772.88 M
+$388.73 M+101.19%
31 December 2023
Summary:
As of January 22, 2025, IDXX annual free cash flow is $772.88 million, with the most recent change of +$388.73 million (+101.19%) on December 31, 2023. During the last 3 years, it has risen by +$232.69 million (+43.08%). IDXX annual FCF is now at all-time high.IDXX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Quarterly FCF
$191.99 M
-$23.02 M-10.71%
30 September 2024
Summary:
As of January 22, 2025, IDXX quarterly free cash flow is $191.99 million, with the most recent change of -$23.02 million (-10.71%) on September 30, 2024. Over the past year, it has dropped by -$46.35 million (-19.45%). IDXX quarterly FCF is now -19.45% below its all-time high of $238.34 million, reached on September 30, 2023.IDXX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX TTM FCF
$792.60 M
-$46.35 M-5.52%
30 September 2024
Summary:
As of January 22, 2025, IDXX TTM free cash flow is $792.60 million, with the most recent change of -$46.35 million (-5.52%) on September 30, 2024. Over the past year, it has increased by +$112.82 million (+16.60%). IDXX TTM FCF is now -5.52% below its all-time high of $838.95 million, reached on June 30, 2024.IDXX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +101.2% | -19.4% | +16.6% |
| 3 y3 years | +43.1% | +54.6% | +106.3% |
| 5 y5 years | +178.9% | +54.6% | +106.3% |
IDXX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.2% | -19.4% | +436.8% | -5.5% | +106.3% |
| 5 y | 5-year | at high | +154.3% | -19.4% | +980.7% | -5.5% | +177.2% |
| alltime | all time | at high | +3613.1% | -19.4% | +307.7% | -5.5% | +1945.0% |
IDEXX Laboratories Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $191.99 M(-10.7%) | $792.60 M(-5.5%) |
| June 2024 | - | $215.01 M(+27.7%) | $838.95 M(+5.3%) |
| Mar 2024 | - | $168.31 M(-22.5%) | $796.79 M(+3.1%) |
| Dec 2023 | $772.88 M(+101.2%) | $217.29 M(-8.8%) | $772.88 M(+13.7%) |
| Sept 2023 | - | $238.34 M(+37.9%) | $679.78 M(+14.7%) |
| June 2023 | - | $172.84 M(+19.7%) | $592.76 M(+30.1%) |
| Mar 2023 | - | $144.40 M(+16.3%) | $455.68 M(+18.6%) |
| Dec 2022 | $384.15 M(-39.6%) | $124.20 M(-17.9%) | $384.15 M(-12.3%) |
| Sept 2022 | - | $151.31 M(+323.1%) | $438.12 M(+2.1%) |
| June 2022 | - | $35.76 M(-50.9%) | $429.00 M(-29.0%) |
| Mar 2022 | - | $72.87 M(-59.1%) | $604.61 M(-4.9%) |
| Dec 2021 | $636.00 M(+17.7%) | $178.18 M(+25.3%) | $636.00 M(-4.0%) |
| Sept 2021 | - | $142.19 M(-32.7%) | $662.57 M(-4.5%) |
| June 2021 | - | $211.37 M(+102.7%) | $694.03 M(+4.2%) |
| Mar 2021 | - | $104.26 M(-49.1%) | $666.25 M(+23.3%) |
| Dec 2020 | $540.19 M(+77.7%) | $204.74 M(+17.9%) | $540.19 M(+21.4%) |
| Sept 2020 | - | $173.66 M(-5.4%) | $444.94 M(+21.5%) |
| June 2020 | - | $183.59 M(-942.2%) | $366.23 M(+28.1%) |
| Mar 2020 | - | -$21.80 M(-119.9%) | $285.96 M(-5.9%) |
| Dec 2019 | $303.93 M(+9.7%) | $109.50 M(+15.3%) | $303.93 M(+4.7%) |
| Sept 2019 | - | $94.94 M(-8.1%) | $290.24 M(+5.8%) |
| June 2019 | - | $103.32 M(-2799.1%) | $274.29 M(+4.6%) |
| Mar 2019 | - | -$3.83 M(-104.0%) | $262.15 M(-5.4%) |
| Dec 2018 | $277.15 M(-6.5%) | $95.80 M(+21.3%) | $277.15 M(-1.2%) |
| Sept 2018 | - | $78.99 M(-13.4%) | $280.46 M(-5.3%) |
| June 2018 | - | $91.18 M(+716.1%) | $296.02 M(-1.4%) |
| Mar 2018 | - | $11.17 M(-88.7%) | $300.12 M(+1.2%) |
| Dec 2017 | $296.57 M(+8.2%) | $99.11 M(+4.8%) | $296.57 M(+4.7%) |
| Sept 2017 | - | $94.56 M(-0.7%) | $283.38 M(+2.3%) |
| June 2017 | - | $95.27 M(+1149.2%) | $277.05 M(+0.1%) |
| Mar 2017 | - | $7.63 M(-91.1%) | $276.70 M(+0.9%) |
| Dec 2016 | $274.16 M(+97.4%) | $85.92 M(-2.6%) | $274.16 M(+8.7%) |
| Sept 2016 | - | $88.23 M(-7.1%) | $252.16 M(+14.5%) |
| June 2016 | - | $94.92 M(+1767.1%) | $220.24 M(+21.3%) |
| Mar 2016 | - | $5.08 M(-92.0%) | $181.63 M(+30.8%) |
| Dec 2015 | $138.88 M(-20.7%) | $63.93 M(+13.5%) | $138.88 M(+64.9%) |
| Sept 2015 | - | $56.30 M(-0.0%) | $84.23 M(-19.1%) |
| June 2015 | - | $56.31 M(-249.5%) | $104.10 M(-9.8%) |
| Mar 2015 | - | -$37.66 M(-505.7%) | $115.44 M(-34.1%) |
| Dec 2014 | $175.15 M(+4.7%) | $9.28 M(-87.8%) | $175.15 M(-18.6%) |
| Sept 2014 | - | $76.17 M(+12.6%) | $215.13 M(+6.8%) |
| June 2014 | - | $67.65 M(+206.9%) | $201.41 M(+6.5%) |
| Mar 2014 | - | $22.05 M(-55.2%) | $189.14 M(+13.0%) |
| Dec 2013 | $167.36 M(+2.1%) | $49.26 M(-21.1%) | $167.36 M(-3.1%) |
| Sept 2013 | - | $62.45 M(+12.8%) | $172.63 M(+4.0%) |
| June 2013 | - | $55.38 M(>+9900.0%) | $165.94 M(+4.2%) |
| Mar 2013 | - | $264.00 K(-99.5%) | $159.32 M(-2.8%) |
| Dec 2012 | $163.89 M(-2.0%) | $54.53 M(-2.2%) | $163.89 M(+7.1%) |
| Sept 2012 | - | $55.76 M(+14.4%) | $153.00 M(-3.6%) |
| June 2012 | - | $48.76 M(+907.9%) | $158.70 M(+1.4%) |
| Mar 2012 | - | $4.84 M(-88.9%) | $156.43 M(-6.5%) |
| Dec 2011 | $167.24 M(+19.9%) | $43.65 M(-29.0%) | $167.24 M(+3.2%) |
| Sept 2011 | - | $61.45 M(+32.2%) | $162.03 M(+12.4%) |
| June 2011 | - | $46.49 M(+197.2%) | $144.16 M(-0.3%) |
| Mar 2011 | - | $15.64 M(-59.3%) | $144.59 M(+3.6%) |
| Dec 2010 | $139.53 M(+12.7%) | $38.44 M(-11.8%) | $139.53 M(-4.3%) |
| Sept 2010 | - | $43.59 M(-7.1%) | $145.74 M(+10.6%) |
| June 2010 | - | $46.92 M(+343.1%) | $131.77 M(+0.5%) |
| Mar 2010 | - | $10.59 M(-76.3%) | $131.06 M(+5.9%) |
| Dec 2009 | $123.79 M(+177.0%) | $44.65 M(+50.7%) | $123.79 M(+40.3%) |
| Sept 2009 | - | $29.62 M(-35.9%) | $88.21 M(+13.7%) |
| June 2009 | - | $46.20 M(+1290.7%) | $77.58 M(+14.0%) |
| Mar 2009 | - | $3.32 M(-63.4%) | $68.07 M(+52.3%) |
| Dec 2008 | $44.69 M | $9.06 M(-52.3%) | $44.69 M(-68.0%) |
| Sept 2008 | - | $18.99 M(-48.3%) | $139.51 M(+3.6%) |
| June 2008 | - | $36.70 M(-282.9%) | $134.64 M(-4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$20.06 M(-119.3%) | $141.24 M(+105.1%) |
| Dec 2007 | $68.88 M(+79.0%) | $103.89 M(+635.6%) | $68.88 M(-384.5%) |
| Sept 2007 | - | $14.12 M(-67.4%) | -$24.21 M(+15.6%) |
| June 2007 | - | $43.30 M(-146.8%) | -$20.95 M(-51.2%) |
| Mar 2007 | - | -$92.43 M(-956.4%) | -$42.96 M(-211.7%) |
| Dec 2006 | $38.47 M(-53.2%) | $10.79 M(-37.9%) | $38.47 M(-25.4%) |
| Sept 2006 | - | $17.38 M(-18.4%) | $51.60 M(-22.0%) |
| June 2006 | - | $21.29 M(-293.6%) | $66.13 M(-12.3%) |
| Mar 2006 | - | -$11.00 M(-146.0%) | $75.39 M(-8.2%) |
| Dec 2005 | $82.13 M(+744.0%) | $23.93 M(-25.0%) | $82.13 M(+227.0%) |
| Sept 2005 | - | $31.91 M(+4.4%) | $25.12 M(+127.5%) |
| June 2005 | - | $30.55 M(-818.2%) | $11.04 M(+1258.1%) |
| Mar 2005 | - | -$4.25 M(-87.1%) | $813.00 K(-91.6%) |
| Dec 2004 | $9.73 M(-90.0%) | -$33.09 M(-285.6%) | $9.73 M(-84.7%) |
| Sept 2004 | - | $17.84 M(-12.3%) | $63.71 M(-3.6%) |
| June 2004 | - | $20.32 M(+335.7%) | $66.10 M(-12.7%) |
| Mar 2004 | - | $4.67 M(-77.7%) | $75.75 M(-22.3%) |
| Dec 2003 | $97.53 M(+13.8%) | $20.89 M(+3.3%) | $97.53 M(+21.9%) |
| Sept 2003 | - | $20.22 M(-32.5%) | $79.98 M(-16.6%) |
| June 2003 | - | $29.97 M(+13.3%) | $95.92 M(+4.8%) |
| Mar 2003 | - | $26.45 M(+693.5%) | $91.52 M(+6.8%) |
| Dec 2002 | $85.72 M(+195.8%) | $3.33 M(-90.8%) | $85.72 M(-7.6%) |
| Sept 2002 | - | $36.16 M(+41.4%) | $92.79 M(+23.6%) |
| June 2002 | - | $25.57 M(+23.7%) | $75.05 M(+26.7%) |
| Mar 2002 | - | $20.66 M(+98.6%) | $59.24 M(+104.4%) |
| Dec 2001 | $28.98 M(+127.9%) | $10.40 M(-43.5%) | $28.98 M(+21.0%) |
| Sept 2001 | - | $18.42 M(+88.9%) | $23.96 M(+134.9%) |
| June 2001 | - | $9.75 M(-201.6%) | $10.20 M(+52.8%) |
| Mar 2001 | - | -$9.60 M(-278.3%) | $6.68 M(-47.5%) |
| Dec 2000 | $12.72 M(-68.4%) | $5.38 M(+15.5%) | $12.72 M(-42.0%) |
| Sept 2000 | - | $4.66 M(-25.2%) | $21.94 M(-16.5%) |
| June 2000 | - | $6.23 M(-275.2%) | $26.27 M(-37.5%) |
| Mar 2000 | - | -$3.56 M(-124.3%) | $42.05 M(+4.6%) |
| Dec 1999 | $40.20 M(-2110.0%) | $14.60 M(+62.2%) | $40.20 M(-446.6%) |
| Sept 1999 | - | $9.00 M(-59.1%) | -$11.60 M(+24.7%) |
| June 1999 | - | $22.00 M(-507.4%) | -$9.30 M(-29.5%) |
| Mar 1999 | - | -$5.40 M(-85.5%) | -$13.20 M(+560.0%) |
| Dec 1998 | -$2.00 M(-90.9%) | -$37.20 M(-429.2%) | -$2.00 M(-113.6%) |
| Sept 1998 | - | $11.30 M(-37.6%) | $14.70 M(+406.9%) |
| June 1998 | - | $18.10 M(+212.1%) | $2.90 M(-135.4%) |
| Mar 1998 | - | $5.80 M(-128.3%) | -$8.20 M(-62.7%) |
| Dec 1997 | -$22.00 M(+478.9%) | -$20.50 M(+4000.0%) | -$22.00 M(+3042.9%) |
| Sept 1997 | - | -$500.00 K(-107.1%) | -$700.00 K(-83.3%) |
| June 1997 | - | $7.00 M(-187.5%) | -$4.20 M(0.0%) |
| Mar 1997 | - | -$8.00 M(-1100.0%) | -$4.20 M(+10.5%) |
| Dec 1996 | -$3.80 M(-58.2%) | $800.00 K(-120.0%) | -$3.80 M(-47.9%) |
| Sept 1996 | - | -$4.00 M(-157.1%) | -$7.30 M(+180.8%) |
| June 1996 | - | $7.00 M(-192.1%) | -$2.60 M(-86.1%) |
| Mar 1996 | - | -$7.60 M(+181.5%) | -$18.70 M(+105.5%) |
| Dec 1995 | -$9.10 M(-187.5%) | -$2.70 M(-485.7%) | -$9.10 M(+71.7%) |
| Sept 1995 | - | $700.00 K(-107.7%) | -$5.30 M(+76.7%) |
| June 1995 | - | -$9.10 M(-555.0%) | -$3.00 M(-127.3%) |
| Mar 1995 | - | $2.00 M(+81.8%) | $11.00 M(+5.8%) |
| Dec 1994 | $10.40 M(+96.2%) | $1.10 M(-63.3%) | $10.40 M(-1.9%) |
| Sept 1994 | - | $3.00 M(-38.8%) | $10.60 M(+27.7%) |
| June 1994 | - | $4.90 M(+250.0%) | $8.30 M(+56.6%) |
| Mar 1994 | - | $1.40 M(+7.7%) | $5.30 M(0.0%) |
| Dec 1993 | $5.30 M(-320.8%) | $1.30 M(+85.7%) | $5.30 M(+32.5%) |
| Sept 1993 | - | $700.00 K(-63.2%) | $4.00 M(+17.6%) |
| June 1993 | - | $1.90 M(+35.7%) | $3.40 M(-1800.0%) |
| Mar 1993 | - | $1.40 M(>+9900.0%) | -$200.00 K(-91.7%) |
| Dec 1992 | -$2.40 M(-57.1%) | $0.00(-100.0%) | -$2.40 M(0.0%) |
| Sept 1992 | - | $100.00 K(-105.9%) | -$2.40 M(-4.0%) |
| June 1992 | - | -$1.70 M(+112.5%) | -$2.50 M(+212.5%) |
| Mar 1992 | - | -$800.00 K | -$800.00 K |
| Dec 1991 | -$5.60 M | - | - |
FAQ
- What is IDEXX Laboratories annual free cash flow?
- What is the all time high annual FCF for IDEXX Laboratories?
- What is IDEXX Laboratories annual FCF year-on-year change?
- What is IDEXX Laboratories quarterly free cash flow?
- What is the all time high quarterly FCF for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly FCF year-on-year change?
- What is IDEXX Laboratories TTM free cash flow?
- What is the all time high TTM FCF for IDEXX Laboratories?
- What is IDEXX Laboratories TTM FCF year-on-year change?
What is IDEXX Laboratories annual free cash flow?
The current annual FCF of IDXX is $772.88 M
What is the all time high annual FCF for IDEXX Laboratories?
IDEXX Laboratories all-time high annual free cash flow is $772.88 M
What is IDEXX Laboratories annual FCF year-on-year change?
Over the past year, IDXX annual free cash flow has changed by +$388.73 M (+101.19%)
What is IDEXX Laboratories quarterly free cash flow?
The current quarterly FCF of IDXX is $191.99 M
What is the all time high quarterly FCF for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly free cash flow is $238.34 M
What is IDEXX Laboratories quarterly FCF year-on-year change?
Over the past year, IDXX quarterly free cash flow has changed by -$46.35 M (-19.45%)
What is IDEXX Laboratories TTM free cash flow?
The current TTM FCF of IDXX is $792.60 M
What is the all time high TTM FCF for IDEXX Laboratories?
IDEXX Laboratories all-time high TTM free cash flow is $838.95 M
What is IDEXX Laboratories TTM FCF year-on-year change?
Over the past year, IDXX TTM free cash flow has changed by +$112.82 M (+16.60%)